Family Dollar AMBI Skincare Sunscreen Recalled for Improper Storage
Family Dollar is recalling an AMBI Skincare Even & Clear Nourishing Daily Facial Moisturizer (SPF 30) for improper storage. The product may have reduced efficacy.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall with no reported illnesses or injuries. The hazard is potential loss of sunscreen efficacy due to storage temperature deviation, which is a theoretical risk. Per the rubric, recalls with no reported harm and theoretical hazards involving voluntary precautionary measures for quality/potency issues are classified as Moderate.
Plain-English summary
Family Dollar Stores is recalling Only At Family Dollar AMBI Skincare Even & Clear Nourishing Daily Facial Moisturizer With Broad Spectrum SPF 30 Sunscreen (1.7 FL. OZ./50 mL, SKU 2096628) nationwide.
The product was stored outside of its labeled temperature requirements. This storage deviation may have compromised the product's potency and efficacy.
The recalled product was distributed nationwide in the United States. All consumers who purchased this product should verify they have a unit matching the recalled SKU.
Consumers should discontinue use of the recalled product and may contact Family Dollar Stores with questions or concerns about the recall.
The recalled product
- Product
- Only At Family Dollar AMBI Skincare Even & Clear Nourishing Daily Facial Moisturizer With Broad Spectrum SPF 30 Sunscreen, Net Wt. 1.7 FL. OZ. (50 mL)
- Manufacturer
- Family Dollar Stores, Llc.
- Hazard
- storage-deviation
- reduced-efficacy
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- SKUs 2096628.
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27